NTR:TSXNutrien Ltd. Analysis

Nutrien Ltd. (NTR) is trading in a strong bullish zone, with the price of C$102.34 sitting comfortably above the 20‑day (C$99.57), 50‑day (C$94.33) and 200‑day (C$84.53) simple moving averages. The RSI of 60.5 and a bullish MACD crossover (line = 2.41, signal = 2.37) reinforce momentum, while the support level at C$94.51 and resistance near C$106.38 frame a healthy upside corridor. Volume is on an upward trend, volatility over the past 30 days is elevated at roughly 28 %, yet the computed beta of 0.30 signals low systematic risk, a fact echoed by the “Extreme Greed” market sentiment reading of 77.55. Technical indicators therefore suggest continued short‑term strength.
Fundamentally, the company posted $25.95 B in revenue with 5.7 % growth, solid gross (32 %) and operating margins (12.7 %), and a dividend yield of 2.91 % backed by a modest payout ratio of 46.8 %. However, the DCF‑derived fair value of C$26.16 implies the current price is significantly overvalued, a view supported by a modest –1.8 % upside/downside metric. The recent approval to launch a normal‑course issuer bid to repurchase up to 5 % of shares, combined with a consensus “Buy” rating and target median price of C$102.83, adds a positive catalyst but does not fully offset valuation concerns. The dividend appears sustainable given strong operating cash flow and free cash flow generation.